查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1628867

生物共轭市场，按类型、按技术、按产品、按生物共轭类型、按应用、按治疗领域、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Bioconjugation Market, By Type, By Technique, By Offering, By Bioconjugation Type, By Application, By Therapeutic Area, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年生物共轭市场规模为51.2232亿美元，2024年至2032年复合年增长率为15.2%。

生物共轭市场-市场动态

抗体药物偶联物（ADC）需求不断成长，推动市场需求

ADC 是生物共轭的关键应用，由于其标靶癌症疗法，预计将出现强劲增长。此外，生物治疗药物在慢性疾病治疗的广泛应用也促进了生物共轭研究。然而，先进的生物共轭技术需要大量的财务投资，限制了小公司的可及性。相反，新颖的结合工具提高了效率，鼓励在诊断和个人化医疗中更广泛的应用。此外，增加资金支持研发，为生物共轭市场成长创造新途径。

生物共轭市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 15.2% 左右的复合年增长率成长

根据类型细分，预计天然生物共轭将在 2023 年显示最大的市场份额

从技术细分来看，2023年酰胺键形成为主导类型

从产品细分来看，2023年服务业是主导类型

基于生物共轭类型细分，蛋白质生物共轭是2023年的主导类型

从应用细分来看，治疗型是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

生物共轭市场-細項分析：

全球生物共轭市场根据类型、技术、产品、生物共轭类型、应用、治疗领域、最终用户和地区进行细分。

市场依类型分为两类：合成生物结合物和天然生物结合物。由于天然生物共轭物在生物製剂和药物开发中的广泛应用，具有高特异性和与生物系统的兼容性，预计将主导生物共轭市场。

根据技术，市场分为五类：酰胺键形成、点击化学、生物正交反应、酵素法以及硫醇-马来酰亚胺偶联。酰胺键形成领域在市场中占据主导地位，并可能在预测期内保持其主导地位。这是由于它广泛用于连接生物分子以进行治疗和诊断应用。其稳定性和效率使其受到广泛的青睐。

生物共轭市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

生物共轭市场-竞争格局：

在对标靶治疗和药物传递创新的需求不断增长的推动下，生物结合市场出现了新技术的研发投资、扩大应用的合作伙伴关係以及透过先进的结合技术实现产品差异化等策略。公司专注于优化连结器和有效负载，以提高功效和安全性。此外，市场强调监管合规性和扩大製造能力，以满足生物製药和诊断领域不断增长的需求。这些策略共同增强了市场竞争力，并促进了下一代治疗解决方案的发展。

最新进展：

2024 年 11 月，Lonza 宣布正在扩建位于瑞士菲斯普的生物共轭工厂，增加两个 1,200 L 製造套件和基础设施，创造 200 个工作机会。预计将于 2028 年开始营运。

2024 年 3 月，Abzena 宣布正在扩大位于宾州布里斯託的生物共轭物生产基地，投资 500 万美元购买新设备、升级设施和增强实验室空间，从而提高生物製药计画的能力。

目录

第一章：生物共轭市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的生物共轭市场片段
    • 生物共轭市场技术片段
    • 生物共轭市场片段（依产品分类）
    • 以生物共轭类型分類的生物共轭市场片段
    • 按应用分類的生物共轭市场片段
    • 按治疗领域分類的生物共轭市场片段
    • 最终用户的生物共轭市场片段
    • 按国家/地区分類的生物共轭市场片段
    • 按地区分類的生物共轭市场片段
  • 竞争洞察

第 3 章：生物共轭主要市场趋势

  • 生物共轭市场驱动因素
    • 市场驱动因素的影响分析
  • 生物共轭市场限制
    • 市场限制影响分析
  • 生物共轭市场机会
  • 生物共轭市场未来趋势

第 4 章：生物结合产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物结合市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：生物结合市场格局

  • 2023 年生物共轭市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物共轭市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 天然生物结合物
    • 合成生物结合物

第 8 章：生物共轭市场 - 依技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 酰胺键的形成
    • 点击化学
    • 生物正交反应
    • 硫醇-马来酰亚胺偶联
    • 酵素法

第 9 章：生物结合市场 - 透过提供

  • 概述
    • 按产品分类的细分市场占有率分析
    • 试剂和试剂盒
    • 服务
      • ADC 製程开发
      • 原料药製造
      • 分析开发
      • 早期开发生物共轭服务
      • 靶向剂或载体蛋白服务
      • 有效负载和链接器製造

第 10 章：生物共轭市场 - 依生物共轭类型

  • 概述
    • 按生物共轭类型分類的细分市场份额分析
    • 寡核苷酸生物共轭
      • 单股寡核苷酸
      • 双股寡核苷酸
    • 聚合物生物共轭
    • 肽生物共轭
    • 蛋白质生物共轭

第 11 章：生物共轭市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 诊断
    • 治疗性
      • 疫苗
      • 单株抗体
      • 抗生素
    • 研究与开发

第 12 章：生物共轭市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 传染病
    • 免疫学
    • 心血管疾病
    • 肿瘤学

第 13 章：生物共轭市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生技公司
    • 学术研究机构
    • 製药公司
    • 合约研究组织

第 14 章：生物结合市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物共轭主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模与预测（按产品划分）
    • 北美市场规模和预测（按生物共轭类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（按治疗领域）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物共轭主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模与预测（按产品划分）
    • 欧洲市场规模和预测（按生物共轭类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按治疗领域）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物共轭主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按产品划分）
    • 亚太地区市场规模和预测（按生物共轭类型）
    • 亚太地区市场规模与预测（按应用）
    • 按治疗领域分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物共轭主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按产品划分）
    • 拉丁美洲市场规模和预测（按生物共轭类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲生物共轭主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按产品划分）
    • 中东和非洲市场规模及预测（按生物共轭类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 15 章：主要供应商分析 - 生物共轭产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • AbbVie Inc.
    • Abcam plc
    • Abzena Limited
    • Agilent Technologies, Inc.
    • AstraZeneca PLC
    • Biocon Limited
    • Bio-Techne Corporation
    • Boehringer Ingelheim GmbH
    • Charles River Laboratories International, Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche AG
    • Innovagen AB
    • Lonza Group AG
    • Johnson & Johnson Services Inc.
    • Merck KGaA
    • Sanofi SA
    • Pfizer Inc.
    • Sartorius AG
    • Sutro Biopharma, Inc.
    • Sorrento Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co., Ltd.
    • Others

第 16 章：360 度分析师视角

第 17 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4390

REPORT HIGHLIGHT

Bioconjugation market size was valued at USD 5,122.32 Million in 2023, expanding at a CAGR of 15.2% from 2024 to 2032.

Bioconjugation is the process of chemically linking two biomolecules, such as proteins, antibodies, or nucleic acids, to enhance their functionality or specificity. This technique is widely applied in drug development, diagnostics, and imaging. By attaching therapeutic agents or markers to biomolecules, bioconjugation enables targeted delivery, improved stability, and reduced side effects. It is a cornerstone in developing antibody-drug conjugates, biosensors, and personalized medicine, significantly advancing biotherapeutics and biomedical research.

Bioconjugation Market- Market Dynamics

Rising demand for antibody-drug conjugates (ADC) growth to propel market demand

ADCs, a critical application of bioconjugation, are expected to witness strong growth due to their targeted cancer therapies. Besides, expanding applications of biotherapeutics in treating chronic diseases boost bioconjugation research. However, advanced bioconjugation techniques demand significant financial investment, limiting accessibility for smaller firms. On the contrary, novel conjugation tools improve efficiency, encouraging broader applications in diagnostics and personalized medicine. Furthermore, increasing funding supports R&D, creating new avenues for bioconjugation market growth.

Bioconjugation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.2% over the forecast period (2024-2032)

Based on type segmentation, natural bioconjugations was predicted to show maximum market share in the year 2023

Based on technique segmentation, amide bond formation was the leading type in 2023

Based on offering segmentation, services were the leading type in 2023

Based on bioconjugation type segmentation, protein bioconjugation was the leading type in 2023

Based on application segmentation, therapeutic was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioconjugation Market- Segmentation Analysis:

The Global Bioconjugation Market is segmented on the basis of Type, Technique, Offering, Bioconjugation Type, Application, Therapeutic Area, End User, and Region.

The market is divided into two categories based on Type: synthetic bioconjugates and natural bioconjugates. The natural bioconjugates segment is expected to dominate the bioconjugation market due to its widespread application in biologics and drug development, offering high specificity and compatibility with biological systems.

The market is divided into five categories based on Technique: amide bond formation, click chemistry, bio-orthogonal reactions, and enzymatic methods, and thiol-maleimide coupling. The amide bond formation sector dominates the market and is likely to maintain its dominance during the forecast period. This is due to its extensive use in linking biomolecules for therapeutic and diagnostic applications. Its stability and efficiency make it widely preferred.

Bioconjugation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bioconjugation Market- Competitive Landscape:

Driven by the increasing demand for targeted therapies and drug delivery innovations, the bioconjugation market sees strategies like R&D investments for novel technologies, partnerships to expand applications, and product differentiation through advanced conjugation techniques. Companies focus on optimizing linkers and payloads for better efficacy and safety. Additionally, the market emphasizes regulatory compliance and scaling manufacturing capabilities to meet growing demands in biopharmaceuticals and diagnostics. These strategies collectively enhance market competitiveness and enable the development of next-generation therapeutic solutions.

Recent Developments:

In November 2024, Lonza announced that it is expanding its bioconjugation facility in Visp, Switzerland, adding two 1,200 L manufacturing suites and infrastructure, creating 200 jobs. Operations are expected to begin in 2028.

In March 2024, Abzena announced that it is expanding its Bristol, PA bioconjugate manufacturing site with a $5 million investment in new equipment, upgraded facilities, and enhanced laboratory space, boosting biopharmaceutical program capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOCONJUGATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Abcam plc
  • Abzena Limited
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Biocon Limited
  • Bio-Techne Corporation
  • Boehringer Ingelheim GmbH
  • Charles River Laboratories International, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG
  • Innovagen AB
  • Lonza Group AG
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Sanofi S.A.
  • Pfizer Inc.
  • Sartorius AG
  • Sutro Biopharma, Inc.
  • Sorrento Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Others

GLOBAL BIOCONJUGATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural Bioconjugates
  • Synthetic Bioconjugates

GLOBAL BIOCONJUGATION MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Amide Bond Formation
  • Click Chemistry
  • Bio-orthogonal Reactions
  • Thiol-Maleimide Coupling
  • Enzymatic Methods

GLOBAL BIOCONJUGATION MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Services
  • ADC Process Development
  • Drug Substance Manufacturing
  • Analytical Development
  • Early Development Bioconjugate Services
  • Targeting Agent or Carrier Protein Services
  • Payload & Linker Manufacturing

GLOBAL BIOCONJUGATION MARKET, BY BIOCONJUGATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Oligonucleotide Bioconjugation
  • Single-stranded Oligonucleotides
  • Double-stranded Oligonucleotides
  • Polymer Bioconjugation
  • Peptide Bioconjugation
  • Protein Bioconjugation

GLOBAL BIOCONJUGATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutic
  • Vaccines
  • Monoclonal Antibodies
  • Antibiotics
  • Research & Development

GLOBAL BIOCONJUGATION MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Immunology
  • Cardiovascular Disorders
  • Oncology

GLOBAL BIOCONJUGATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology Companies
  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Contract Research Organizations

GLOBAL BIOCONJUGATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioconjugation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioconjugation Market Snippet by Type
    • 2.1.2. Bioconjugation Market Snippet by Technique
    • 2.1.3. Bioconjugation Market Snippet by Offering
    • 2.1.4. Bioconjugation Market Snippet by Bioconjugation Type
    • 2.1.5. Bioconjugation Market Snippet by Application
    • 2.1.6. Bioconjugation Market Snippet by Therapeutic Area
    • 2.1.7. Bioconjugation Market Snippet by End User
    • 2.1.8. Bioconjugation Market Snippet by Country
    • 2.1.9. Bioconjugation Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioconjugation Key Market Trends

  • 3.1. Bioconjugation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioconjugation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioconjugation Market Opportunities
  • 3.4. Bioconjugation Market Future Trends

4. Bioconjugation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioconjugation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioconjugation Market Landscape

  • 6.1. Bioconjugation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioconjugation Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Natural Bioconjugates
    • 7.1.3. Synthetic Bioconjugates

8. Bioconjugation Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
    • 8.1.2. Amide Bond Formation
    • 8.1.3. Click Chemistry
    • 8.1.4. Bio-orthogonal Reactions
    • 8.1.5. Thiol-Maleimide Coupling
    • 8.1.6. Enzymatic Methods

9. Bioconjugation Market - By Offering

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Offering, 2023 & 2032 (%)
    • 9.1.2. Reagents & Kits
    • 9.1.3. Services
      • 9.1.3.1. ADC Process Development
      • 9.1.3.2. Drug Substance Manufacturing
      • 9.1.3.3. Analytical Development
      • 9.1.3.4. Early Development Bioconjugate Services
      • 9.1.3.5. Targeting Agent or Carrier Protein Services
      • 9.1.3.6. Payload & Linker Manufacturing

10. Bioconjugation Market - By Bioconjugation Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Bioconjugation Type, 2023 & 2032 (%)
    • 10.1.2. Oligonucleotide Bioconjugation
      • 10.1.2.1. Single-stranded Oligonucleotides
      • 10.1.2.2. Double-stranded Oligonucleotides
    • 10.1.3. Polymer Bioconjugation
    • 10.1.4. Peptide Bioconjugation
    • 10.1.5. Protein Bioconjugation

11. Bioconjugation Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 11.1.2. Diagnostics
    • 11.1.3. Therapeutic
      • 11.1.3.1. Vaccines
      • 11.1.3.2. Monoclonal Antibodies
      • 11.1.3.3. Antibiotics
    • 11.1.4. Research & Development

12. Bioconjugation Market - By Therapeutic Area

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 12.1.2. Infectious Diseases
    • 12.1.3. Immunology
    • 12.1.4. Cardiovascular Disorders
    • 12.1.5. Oncology

13. Bioconjugation Market - By End User

  • 13.1. Overview
    • 13.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 13.1.2. Biotechnology Companies
    • 13.1.3. Academic & Research Institutions
    • 13.1.4. Pharmaceutical Companies
    • 13.1.5. Contract Research Organizations

14. Bioconjugation Market- By Geography

  • 14.1. Introduction
    • 14.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 14.2. North America
    • 14.2.1. Overview
    • 14.2.2. Bioconjugation Key Manufacturers in North America
    • 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.2.6. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.2.7. North America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.2.9. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.2.10. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.2.11. U.S.
      • 14.2.11.1. Overview
      • 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.11.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.11.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.11.5. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.11.6. U.S. Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.11.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.11.8. U.S. Market Size and Forecast, By Bioconjugation Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.11.9. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.11.10.
    • 14.2.12. Canada
      • 14.2.12.1. Overview
      • 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.12.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.12.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.12.5. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.12.6. Canada Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.12.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.12.8. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.12.9. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.12.10.
  • 14.3. Europe
    • 14.3.1. Overview
    • 14.3.2. Bioconjugation Key Manufacturers in Europe
    • 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.3.6. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.3.7. Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.3.9. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.3.10. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.11. Germany
      • 14.3.11.1. Overview
      • 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.11.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.11.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.11.5. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.11.6. Germany Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.11.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.11.8. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.11.9. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.12. Italy
      • 14.3.12.1. Overview
      • 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.12.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.12.5. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.12.6. Italy Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.12.8. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.12.9. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.13. United Kingdom
      • 14.3.13.1. Overview
      • 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.13.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.13.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.13.5. United Kingdom Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.13.6. United Kingdom Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.13.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.13.8. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.13.9. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.14. France
      • 14.3.14.1. Overview
      • 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.14.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.14.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.14.5. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.14.6. France Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.14.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.14.8. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.14.9. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.15. Russia
      • 14.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.15.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.15.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.15.4. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.15.5. Russia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.15.7. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.15.8. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.16. Netherlands
      • 14.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.16.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.16.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.16.4. Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.16.5. Netherlands Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.16.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.16.7. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.16.8. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.17. Sweden
      • 14.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.17.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.17.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.17.4. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.17.5. Sweden Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.17.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.17.7. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.17.8. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.18. Poland
      • 14.3.18.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.18.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.18.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.18.4. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.18.5. Poland Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.18.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.18.7. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.18.8. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.19. Rest of Europe
      • 14.3.19.1. Overview
      • 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.19.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.19.5. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.19.6. Rest of the Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.19.8. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.19.9. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.4. Asia Pacific (APAC)
    • 14.4.1. Overview
    • 14.4.2. Bioconjugation Key Manufacturers in Asia Pacific
    • 14.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.4.6. Asia Pacific Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.4.7. Asia Pacific Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.4.9. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.4.10. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.11. India
      • 14.4.11.1. Overview
      • 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.11.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.11.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.11.5. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.11.6. India Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.11.8. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.11.9. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.12. China
      • 14.4.12.1. Overview
      • 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.12.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.12.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.12.5. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.12.6. China Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.12.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.12.8. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.12.9. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.13. Japan
      • 14.4.13.1. Overview
      • 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.13.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.13.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.13.5. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.13.6. Japan Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.13.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.13.8. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.13.9. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.14. South Korea
      • 14.4.14.1. Overview
      • 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.14.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.14.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.14.5. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.14.6. South Korea Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.14.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.14.8. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.14.9. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.15. Australia
      • 14.4.15.1. Overview
      • 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.15.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.15.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.15.5. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.15.6. Australia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.15.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.15.8. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.15.9. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.16. Thailand
      • 14.4.16.1. Overview
      • 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.16.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.16.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.16.5. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.16.6. Thailand Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.16.8. hailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.16.9. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.17. Indonesia
      • 14.4.17.1. Overview
      • 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.17.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.17.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.17.5. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.17.6. Indonesia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.17.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.17.8. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.17.9. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.18. Philippines
      • 14.4.18.1. Overview
      • 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.18.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.18.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.18.5. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.18.6. Philippines Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.18.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.18.8. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.18.9. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.19. Rest of APAC
      • 14.4.19.1. Overview
      • 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.19.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.19.5. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.19.6. Rest of APAC Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.19.8. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.19.9. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.5. Latin America
    • 14.5.1. Overview
    • 14.5.2. Bioconjugation Key Manufacturers in Latin America
    • 14.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.5.6. Latin America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.5.7. Latin America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.5.9. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.5.10. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.11. Brazil
      • 14.5.11.1. Overview
      • 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.11.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.11.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.11.5. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.11.6. Brazil Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.11.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.11.8. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.11.9. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.12. Mexico
      • 14.5.12.1. Overview
      • 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.12.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.12.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.12.5. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.12.6. Mexico Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.12.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.12.8. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.12.9. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.13. Argentina
      • 14.5.13.1. Overview
      • 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.13.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.13.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.13.5. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.13.6. Argentina Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.13.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.13.8. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.13.9. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.14. Colombia
      • 14.5.14.1. Overview
      • 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.14.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.14.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.14.5. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.14.6. Colombia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.14.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.14.8. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.14.9. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.15. Rest of LATAM
      • 14.5.15.1. Overview
      • 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.15.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.15.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.15.5. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.15.6. Rest of LATAM Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.15.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.15.8. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.15.9. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.6. Middle East and Africa
    • 14.6.1. Overview
    • 14.6.2. Bioconjugation Key Manufacturers in Middle East and Africa
    • 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.6.6. Middle East and Africa Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.6.7. Middle East and Africa Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.6.9. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.6.10. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.11. Saudi Arabia
      • 14.6.11.1. Overview
      • 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.11.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.11.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.11.5. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.11.6. Saudi Arabia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.11.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.11.8. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.11.9. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.12. United Arab Emirates
      • 14.6.12.1. Overview
      • 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.12.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.12.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.12.5. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.12.6. United Arab Emirates Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.12.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.12.8. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.12.9. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.13. Israel
      • 14.6.13.1. Overview
      • 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.13.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.13.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.13.5. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.13.6. Israel Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.13.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.13.8. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.13.9. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.14. Turkey
      • 14.6.14.1. Overview
      • 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.14.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.14.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.14.5. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.14.6. Turkey Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.14.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.14.8. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.14.9. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.15. Algeria
      • 14.6.15.1. Overview
      • 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.15.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.15.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.15.5. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.15.6. Algeria Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.15.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.15.8. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.15.9. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.16. Egypt
      • 14.6.16.1. Overview
      • 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.16.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.16.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.16.5. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.16.6. Egypt Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.16.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.16.8. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.16.9. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.17. Rest of MEA
      • 14.6.17.1. Overview
      • 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.17.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.17.5. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.17.6. Rest of MEA Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.17.8. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.17.9. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Bioconjugation Industry

  • 15.1. Competitive Dashboard
    • 15.1.1. Competitive Benchmarking
    • 15.1.2. Competitive Positioning
  • 15.2. Company Profiles
    • 15.2.1. AbbVie Inc.
    • 15.2.2. Abcam plc
    • 15.2.3. Abzena Limited
    • 15.2.4. Agilent Technologies, Inc.
    • 15.2.5. AstraZeneca PLC
    • 15.2.6. Biocon Limited
    • 15.2.7. Bio-Techne Corporation
    • 15.2.8. Boehringer Ingelheim GmbH
    • 15.2.9. Charles River Laboratories International, Inc.
    • 15.2.10. Bristol-Myers Squibb Company
    • 15.2.11. Eli Lilly and Company
    • 15.2.12. GlaxoSmithKline plc
    • 15.2.13. F. Hoffmann-La Roche AG
    • 15.2.14. Innovagen AB
    • 15.2.15. Lonza Group AG
    • 15.2.16. Johnson & Johnson Services Inc.
    • 15.2.17. Merck KGaA
    • 15.2.18. Sanofi S.A.
    • 15.2.19. Pfizer Inc.
    • 15.2.20. Sartorius AG
    • 15.2.21. Sutro Biopharma, Inc.
    • 15.2.22. Sorrento Therapeutics, Inc.
    • 15.2.23. Thermo Fisher Scientific Inc.
    • 15.2.24. WuXi AppTec Co., Ltd.
    • 15.2.25. Others

16. 360 Degree Analyst View

17. Appendix

  • 17.1. Research Methodology
  • 17.2. References
  • 17.3. Abbreviations
  • 17.4. Disclaimer
  • 17.5. Contact Us